MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance

Abstract Chemoresistance constitutes a major challenge in the treatment of triple-negative breast cancer (TNBC). Mixed-Lineage Kinase 4 (MLK4) is frequently amplified or overexpressed in TNBC where it facilitates the aggressive growth and migratory potential of breast cancer cells. However, the func...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dawid Mehlich, Michał Łomiak, Aleksandra Sobiborowicz, Alicja Mazan, Dagmara Dymerska, Łukasz M. Szewczyk, Anna Mehlich, Agnieszka Borowiec, Monika K. Prełowska, Adam Gorczyński, Paweł Jabłoński, Ewa Iżycka-Świeszewska, Dominika Nowis, Anna A. Marusiak
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/a6cbcdae3c1744a89c3691e28b0246d5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a6cbcdae3c1744a89c3691e28b0246d5
record_format dspace
spelling oai:doaj.org-article:a6cbcdae3c1744a89c3691e28b0246d52021-11-28T12:04:39ZMLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance10.1038/s41419-021-04405-02041-4889https://doaj.org/article/a6cbcdae3c1744a89c3691e28b0246d52021-11-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04405-0https://doaj.org/toc/2041-4889Abstract Chemoresistance constitutes a major challenge in the treatment of triple-negative breast cancer (TNBC). Mixed-Lineage Kinase 4 (MLK4) is frequently amplified or overexpressed in TNBC where it facilitates the aggressive growth and migratory potential of breast cancer cells. However, the functional role of MLK4 in resistance to chemotherapy has not been investigated so far. Here, we demonstrate that MLK4 promotes TNBC chemoresistance by regulating the pro-survival response to DNA-damaging therapies. We observed that MLK4 knock-down or inhibition sensitized TNBC cell lines to chemotherapeutic agents in vitro. Similarly, MLK4-deficient cells displayed enhanced sensitivity towards doxorubicin treatment in vivo. MLK4 silencing induced persistent DNA damage accumulation and apoptosis in TNBC cells upon treatment with chemotherapeutics. Using phosphoproteomic profiling and reporter assays, we demonstrated that loss of MLK4 reduced phosphorylation of key DNA damage response factors, including ATM and CHK2, and compromised DNA repair via non-homologous end-joining pathway. Moreover, our mRNA-seq analysis revealed that MLK4 is required for DNA damage-induced expression of several NF-кB-associated cytokines, which facilitate TNBC cells survival. Lastly, we found that high MLK4 expression is associated with worse overall survival of TNBC patients receiving anthracycline-based neoadjuvant chemotherapy. Collectively, these results identify a novel function of MLK4 in the regulation of DNA damage response signaling and indicate that inhibition of this kinase could be an effective strategy to overcome TNBC chemoresistance.Dawid MehlichMichał ŁomiakAleksandra SobiborowiczAlicja MazanDagmara DymerskaŁukasz M. SzewczykAnna MehlichAgnieszka BorowiecMonika K. PrełowskaAdam GorczyńskiPaweł JabłońskiEwa Iżycka-ŚwieszewskaDominika NowisAnna A. MarusiakNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 12, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Dawid Mehlich
Michał Łomiak
Aleksandra Sobiborowicz
Alicja Mazan
Dagmara Dymerska
Łukasz M. Szewczyk
Anna Mehlich
Agnieszka Borowiec
Monika K. Prełowska
Adam Gorczyński
Paweł Jabłoński
Ewa Iżycka-Świeszewska
Dominika Nowis
Anna A. Marusiak
MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
description Abstract Chemoresistance constitutes a major challenge in the treatment of triple-negative breast cancer (TNBC). Mixed-Lineage Kinase 4 (MLK4) is frequently amplified or overexpressed in TNBC where it facilitates the aggressive growth and migratory potential of breast cancer cells. However, the functional role of MLK4 in resistance to chemotherapy has not been investigated so far. Here, we demonstrate that MLK4 promotes TNBC chemoresistance by regulating the pro-survival response to DNA-damaging therapies. We observed that MLK4 knock-down or inhibition sensitized TNBC cell lines to chemotherapeutic agents in vitro. Similarly, MLK4-deficient cells displayed enhanced sensitivity towards doxorubicin treatment in vivo. MLK4 silencing induced persistent DNA damage accumulation and apoptosis in TNBC cells upon treatment with chemotherapeutics. Using phosphoproteomic profiling and reporter assays, we demonstrated that loss of MLK4 reduced phosphorylation of key DNA damage response factors, including ATM and CHK2, and compromised DNA repair via non-homologous end-joining pathway. Moreover, our mRNA-seq analysis revealed that MLK4 is required for DNA damage-induced expression of several NF-кB-associated cytokines, which facilitate TNBC cells survival. Lastly, we found that high MLK4 expression is associated with worse overall survival of TNBC patients receiving anthracycline-based neoadjuvant chemotherapy. Collectively, these results identify a novel function of MLK4 in the regulation of DNA damage response signaling and indicate that inhibition of this kinase could be an effective strategy to overcome TNBC chemoresistance.
format article
author Dawid Mehlich
Michał Łomiak
Aleksandra Sobiborowicz
Alicja Mazan
Dagmara Dymerska
Łukasz M. Szewczyk
Anna Mehlich
Agnieszka Borowiec
Monika K. Prełowska
Adam Gorczyński
Paweł Jabłoński
Ewa Iżycka-Świeszewska
Dominika Nowis
Anna A. Marusiak
author_facet Dawid Mehlich
Michał Łomiak
Aleksandra Sobiborowicz
Alicja Mazan
Dagmara Dymerska
Łukasz M. Szewczyk
Anna Mehlich
Agnieszka Borowiec
Monika K. Prełowska
Adam Gorczyński
Paweł Jabłoński
Ewa Iżycka-Świeszewska
Dominika Nowis
Anna A. Marusiak
author_sort Dawid Mehlich
title MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
title_short MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
title_full MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
title_fullStr MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
title_full_unstemmed MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
title_sort mlk4 regulates dna damage response and promotes triple-negative breast cancer chemoresistance
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/a6cbcdae3c1744a89c3691e28b0246d5
work_keys_str_mv AT dawidmehlich mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT michałłomiak mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT aleksandrasobiborowicz mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT alicjamazan mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT dagmaradymerska mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT łukaszmszewczyk mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT annamehlich mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT agnieszkaborowiec mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT monikakprełowska mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT adamgorczynski mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT pawełjabłonski mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT ewaizyckaswieszewska mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT dominikanowis mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
AT annaamarusiak mlk4regulatesdnadamageresponseandpromotestriplenegativebreastcancerchemoresistance
_version_ 1718408216876941312